IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Erratum for Findlow et al., Infect. Immun. 74 (8) 4557-4565.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Findlow, J.
Right arrow Articles by Miller, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Findlow, J.
Right arrow Articles by Miller, E.

 Previous Article  |  Next Article 

Infection and Immunity, August 2007, p. 4187, Vol. 75, No. 8
0019-9567/07/$08.00+0     doi:10.1128/IAI.00768-07

ERRATUM

Comparison and Correlation of Neisseria meningitidis Serogroup B Immunologic Assay Results and Human Antibody Responses following Three Doses of the Norwegian Meningococcal Outer Membrane Vesicle Vaccine MenBvac

Jamie Findlow, Stephen Taylor, Audun Aase, Rachel Horton, Robert Heyderman, Jo Southern, Nick Andrews, Rita Barchha, Ewan Harrison, Ann Lowe, Emma Boxer, Charlotte Heaton, Paul Balmer, Ed Kaczmarski, Philipp Oster, Andrew Gorringe, Ray Borrow, and Elizabeth Miller

Vaccine Evaluation Unit, Health Protection Agency North West, Manchester Laboratory, Manchester Medical Microbiology Partnership, P.O. Box 209, Clinical Sciences Building II, Manchester Royal Infirmary, Manchester M13 9WZ, United Kingdom; Health Protection Agency, Centre for Emergency Preparedness and Response, Salisbury SP4 OJG, United Kingdom; Division of Infectious Disease Control, Norwegian Institute of Public Health, NO-0403 Oslo, Norway; Department of Cellular and Molecular Medicine, School of Medical Sciences, University of Bristol, University Walk, Bristol BS8 1TD, and Bristol HPA Laboratory, Bristol BS2 8HW, United Kingdom; Health Protection Agency, Centre for Infections, Colindale, London NW9 5EQ, United Kingdom; Meningococcal Reference Unit, Health Protection Agency North West, Manchester Laboratory, Manchester Medical Microbiology Partnership, P.O. Box 209, Clinical Sciences Building II, Manchester Royal Infirmary, Manchester M13 9WZ, United Kingdom; and Chiron Vaccines, Via Fiorentina 1, 53100 Siena, Italy

Volume 74, no. 8, p. 4557-4565, 2006. Page 4558, Table 1: For NZ 98/254, the serotype and sequence type should read "4" and "42," respectively.

Infection and Immunity, August 2007, p. 4187, Vol. 75, No. 8
0019-9567/07/$08.00+0     doi:10.1128/IAI.00768-07





This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Findlow, J.
Right arrow Articles by Miller, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Findlow, J.
Right arrow Articles by Miller, E.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals